PCSK9 targets important for lipid metabolism
Schulz, Rainer, Schlüter, Klaus-Dieter
Published in Clinical research in cardiology supplements (01.03.2017)
Published in Clinical research in cardiology supplements (01.03.2017)
Get full text
Journal Article
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
Schettler, V. J. J., Neumann, C. L., Peter, C., Zimmermann, T., Julius, U., Roeseler, E., Heigl, F., Grützmacher, P., Blume, H., Vogt, A.
Published in Clinical research in cardiology supplements (01.03.2017)
Published in Clinical research in cardiology supplements (01.03.2017)
Get full text
Journal Article
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
Julius, U., Tselmin, S., Schatz, U., Fischer, S., Bornstein, S. R.
Published in Clinical research in cardiology supplements (01.04.2019)
Published in Clinical research in cardiology supplements (01.04.2019)
Get full text
Journal Article
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Schettler, V. J. J., Neumann, C. L., Peter, C., Zimmermann, T., Julius, U., Hohenstein, B., Roeseler, E., Heigl, F., Grützmacher, P., Blume, H., Klingel, R., Vogt, A
Published in Clinical research in cardiology supplements (01.04.2019)
Published in Clinical research in cardiology supplements (01.04.2019)
Get full text
Journal Article
Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines
Klingel, Reinhard, Heibges, Andreas, Fassbender, Cordula
Published in Clinical research in cardiology supplements (01.03.2017)
Published in Clinical research in cardiology supplements (01.03.2017)
Get full text
Journal Article
Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism?
Nave, Alexander Heinrich, von Eckardstein, Arnold
Published in Clinical research in cardiology supplements (01.04.2019)
Published in Clinical research in cardiology supplements (01.04.2019)
Get full text
Journal Article
Lipoprotein(a) and mortality—a high risk relationship
Klingel, Reinhard, Heibges, Andreas, Fassbender, Cordula
Published in Clinical research in cardiology supplements (01.04.2019)
Published in Clinical research in cardiology supplements (01.04.2019)
Get full text
Journal Article
Lipoprotein(a)—an interdisciplinary challenge
Julius, U., Tselmin, S., Schatz, U., Fischer, S., Bornstein, S. R.
Published in Clinical research in cardiology supplements (01.04.2019)
Published in Clinical research in cardiology supplements (01.04.2019)
Get full text
Journal Article
Current view: indications for extracorporeal lipid apheresis treatment
Schettler, Volker, Neumann, C. L., Hulpke-Wette, M., Hagenah, G. C., Schulz, E. G., Wieland, E.
Published in Clinical research in cardiology supplements (01.06.2012)
Published in Clinical research in cardiology supplements (01.06.2012)
Get full text
Journal Article
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
Schettler, Volker J. J., Neumann, Class L., Peter, Christian, Zimmermann, Thomas, Julius, Ulrich, Roeseler, Eberhard, Heigl, Franz
Published in Clinical research in cardiology supplements (01.04.2015)
Published in Clinical research in cardiology supplements (01.04.2015)
Get full text
Journal Article
Lipoprotein(a)—clinical aspects and future challenges
Kurt, Bilgen, Soufi, Muhidien, Sattler, Alexander, Schaefer, Juergen R.
Published in Clinical research in cardiology supplements (01.04.2015)
Published in Clinical research in cardiology supplements (01.04.2015)
Get full text
Journal Article